Asia Pacific Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Population Health), End User (Payer, Hospital, ASC), Trend, Market Share, Growth - Forecast to 2030

icon1
USD 41.88 BN
MARKET SIZE, 2030
icon2
CAGR 25.2%
(2025-2030)
icon3
350
REPORT PAGES
icon4
300
MARKET TABLES

OVERVIEW

Asia Pacific Healthcare Analytics Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Asia Pacific healthcare analytics market, valued at US$10.94 billion in 2024, stood at US$13.63 billion in 2025 and is projected to advance at a resilient CAGR of 25.2% from 2024 to 2030, culminating in a forecasted valuation of US$41.88 billion by the end of the period. The growth of the Asia Pacific healthcare analytics market is driven by the increase in government-led digital health strategies and regional action frameworks.

KEY TAKEAWAYS

  • By Country
    The Asia Pacific healthcare analytics market for China accounted for a 38.2% revenue share in 2024.
  • By Component
    By component, the services segment is expected to register the highest CAGR of 25.7%.
  • By Type
    By type, the prescriptive analytics segment is projected to grow at the fastest rate from 2025 to 2030.
  • By Application
    By application, the clinical analytics segment is expected to dominate the market.
  • By End Use
    By end use, the providers segment accounted for the largest share, with a 44.4% revenue share in 2024.
  • Competitive Landscape
    Merative, SAS Institute Inc., and Optum, Inc. were identified as some of the star players in the Asia Pacific healthcare analytics market, given their strong market share and product footprint.
  • Competitive Landscape
    Tredence Inc, Heaps Health Solutions India Private Limited, and Myhealthcare Technologies Private Limited, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders

The healthcare analytics market in Asia Pacific is a growing segment, driven by the need for information-driven healthcare decisions, including the development and utilization of AI-powered clinical insights and predictive capabilities to enhance patient outcomes at reduced expenditures. Some recent breakthroughs include strategic partnerships with healthcare systems and vendors of analytics solutions, investments in cloud-based analytics platform infrastructure, and innovations in real-world evidence (RWE), population health analytics, and interoperability solutions, which are leading to a revolution in this industry landscape and accelerating digital health maturity.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The Asia Pacific healthcare analytics market is seeing drastic changes due to various key trends and disruptions. These are changing the way industries deploy healthcare analytics solutions across various sectors and have also indicated a gradual shift from conventional models to advanced, data-driven solutions. AI-driven predictive analytics, value-based care models, interoperability, and increased data integration are emerging as vital levers for future revenue pools. Additionally, regulatory compliance, data security, and new technologies such as machine learning, artificial intelligence, IoT, cloud computing, and blockchain are gaining traction among clients, including private insurance firms, government agencies, hospitals, and post-acute care organizations. All these trends will drive the evolution in customer business models, leading to better decision-making, improved patient care, and higher operational efficiencies.

Asia Pacific Healthcare Analytics Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Government-led digital health strategies and regional action frameworks
  • Increase in digital health funding in AI and analytics
RESTRAINTS
Impact
Level
  • High cost of healthcare analytics solutions
  • Cybersecurity & patient-data breach risk
OPPORTUNITIES
Impact
Level
  • Shift toward value-based care and outcome-driven medicines
  • Growing penetration of digital health platforms, mobile health apps, and social media data
CHALLENGES
Impact
Level
  • Reluctance to adopt healthcare analytics solutions in developing countries
  • Data quality, accuracy, and standardization issues across care settings

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Government-led digital health strategies and regional action frameworks

The presence of government-led digital healthcare strategies and regional action plans is a major driver in the Asia Pacific healthcare analytics market. India, Singapore, Australia, China, and Japan have established country-wide digital healthcare strategies with an emphasis on setting standards for health information and developing regional healthcare analytics tools with higher interoperability. Programs such as the National Digital Health Mission in India, Healthier SG in Singapore, and Healthy China 2030 in China are creating awareness among medical institutions and bodies in this region about future healthcare solutions, including EHR integration, real-time information exchange, and AI-enabled analytics solutions.

Restraint: High cost of healthcare analytics solutions

A major factor restricting the Asia Pacific healthcare analytics market is the high cost of healthcare analytics solutions. Sophisticated analytics solutions, AL-enabled predictive solutions, and cloud architectures tend to have a higher setup and maintenance cost and need specialized manpower. Moreover, small and medium-sized medical institutions in the Asia Pacific may have budget limitations for investing in advanced analytics solutions. A major setback in adopting advanced healthcare analytics solutions in the Asia Pacific countries is the cost of integrating these solutions with existing electronic medical record systems. The cost of integration with less advanced digital infrastructure in developing economies might be a major hurdle in the Asia Pacific healthcare analytics market.

Opportunity: Shift toward value-based care and outcome-driven medicines

The emerging focus on value-based healthcare and outcomes-oriented medicine has emerged as a key opportunity for the healthcare analytics market in the Asia Pacific. With a growing urge to derive better patient outcomes, optimization of resources, and strategic preventive measures, healthcare providers and buyers have increasingly turned to healthcare analytics. AI-powered predictive modeling, real-time analytical solutions, and evidence-driven healthcare pathways can help in performance tracking and population healthcare management. Analytics solutions were part of nationally launched programs in countries such as India, Singapore, Australia, and Japan, promoting outcome-based payment in these regions.

Challenge: Reluctance to adopt healthcare analytics solutions in developing countries

In developing countries, there is a lack of developed infrastructure in terms of digital development, a shortage of skilled professionals, and basic privacy concerns, which makes it difficult for many of these nations to adopt analytics solutions in their hospitals. In many of these countries, a traditional method of handling patients’ data and decision-making is followed, which delays many countries in adopting AI-powered analytics solutions in cloud platforms.

ASIA PACIFIC HEALTHCARE ANALYTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Claims-based healthcare analytics using Truven’s extensive MarketScan claims databases to identify cost drivers, utilization patterns, and treatment effectiveness across large populations Enables payers, providers, and life sciences organizations to optimize care pathways| Reduce unnecessary costs through data-backed insights on real-world utilization and outcomes
Fraud, Waste & Abuse (FWA) analytics using advanced machine learning and anomaly detection on claims data Reduces payer financial losses by accurately identifying inappropriate or fraudulent claims
Population health and risk management analytics using integrated clinical + claims datasets through Optum’s analytics platform Improves chronic disease management| Lowers medical cost by identifying high-risk members earlier
EHR-integrated clinical analytics powered by Oracle Cloud, providing real-time dashboards for hospital operations, quality, and clinical risk indicators Enhances clinical efficiency and operational performance through real-time, cloud-scalable insights
Real-world data analytics using Veradigm’s EHR network to support life sciences in drug safety, effectiveness, and market access studies Accelerates RWE generation for pharma| Reduces the time needed for regulatory and commercial decision support.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The Asia Pacific healthcare analytics market ecosystem comprises a chain of software companies, service companies, system integrators, and various organizations in the Asia Pacific region that combine efforts to deliver analytics-driven patient care. Software companies develop analytics platforms, including clinical decision support, predictive analytics, population health management, and analytics-driven optimization, whereas service companies assist with implementation, training, and managed analytics services. The task of system integrators is to interface the analytics platforms and offerings from the other components of the ecosystem, including electronic health record, imaging, laboratory information, and hospital information infrastructure in Asia Pacific hospitals, clinics, and public health organizations, who are the key consumers in the Asia Pacific healthcare analytics market ecosystem.

Asia Pacific Healthcare Analytics Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Asia Pacific Healthcare Analytics Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Asia Pacific Healthcare Analytics Market, By Component

As of 2024, the health care analytics market in the Asia Pacific is led by the services sector and will continue the trend till 2025. This can largely be attributed to the fact that the requirement for data integration, implementation, and analytics consulting support is on the rise due to the increase in the adoption of advanced digital technologies by the healthcare sector. This also helps organizations leverage analytics platforms and make them operational and compatible with healthcare EHRs. There is a requirement for customized prediction models, which contributes to the importance of the healthcare analytics services sector.

Asia Pacific Healthcare Analytics Market, By Type

In 2024, descriptive analytics led the Asia Pacific market for healthcare analytics due to an increasing demand for basic reporting, analysis, and visualization capabilities among hospitals, payers, and government agencies. Healthcare organizations and payers utilize descriptive analytics to analyze retrospective data related to patients’ health, finances, and operational outcomes. Additionally, they utilize it for tracking key indicators of these operational aspects. It acts as an entry level for quality reporting, claims analysis, or population health analysis before using more advanced analytics such as predictive or prescriptive analytics. With the increasing digitization of health organizations, transparency remains an essential component for organizations related to compliance and data-driven decision-making processes.

Asia Pacific Healthcare Analytics Market, By Application

The clinical analytics segment has the largest share in the Asia Pacific healthcare analytics market as it offers the most direct benefit to the patients. The major drivers for the clinical analytics segment in this market are the increasing adoption of analytics for early intervention, the adoption of EHR-based analytics, and the advancement in analytical technologies. The segment has witnessed the most growth due to the increasing importance of patient outcomes and the optimization of patient care processes. The segment will grow in the future due to the increasing importance of patient outcomes in the Asia Pacific region.

Asia Pacific Healthcare Analytics Market, By End User

The providers segment is expected to have the largest share in the Asia Pacific market for healthcare analytics, by end user. This is because the healthcare provider sector produces the highest amount of data related to healthcare and operations. Providers are among the most active users of analytics, primarily working to increase positive healthcare outcomes and optimize workflow efficiency, thereby reducing readmissions and adopting a value-based approach in healthcare delivery. The rise of electronic health records, clinical decision support solutions, and population health platforms has further fueled this adoption.

REGION

India to be fastest-growing country in Asia Pacific healthcare analytics market during forecast period

With the encouragement of the government in the form of the National Digital Health Mission and the adoption of electronic health record systems, India is the fastest-growing country in the Asia Pacific healthcare analytics market. The spending on AI-enabled clinical decision support solutions, population health platforms, and cloud infrastructure solutions in the medical industry is leading to the adoption of these solutions. India is going to become the most dynamic market in the Asia Pacific region in the medical industry.

Asia Pacific Healthcare Analytics Market Region

ASIA PACIFIC HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX

In the Asia Pacific healthcare analytics market matrix, Optum, Inc. (Star) has a strong market presence with a considerable market share due to its massive data assets and AI-driven platforms. CitiusTech Inc. (Emerging Leader) is slowly emerging with a focus on healthcare analytics, its interoperability advantages, and a focus on developing healthcare-specific platforms. Optum has a significant potential to retain its position due to its extensive data assets and AI-driven healthcare analytics platforms. On the other hand, CitiusTech has a massive potential to move into the leading position due to the acceleration in the use of AI-driven healthcare analytics.

Asia Pacific Healthcare Analytics Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

  • Merative (US)
  • SAS Institute Inc. (US)
  • Optum, Inc. (US)
  • Oracle (US)
  • Veradigm LLC (US)
  • ExlService Holdings, Inc. (US)
  • CitiusTech Inc. (US)
  • Health Catalyst (US)
  • CVS Health (US)
  • Inovalon (US)
  • McKesson Corporation (US)
  • Cotiviti, Inc. (US)
  • Apixio, Inc. (US)
  • Enlitic (US)
  • Komodo Health, Inc. (US)
  • HealthEC, LLC (US)
  • IQVIA (US)
  • Wipro (India)
  • InterSystems Corporation (US)
  • Koninklijke Philips N.V. (Netherland)
  • Infor(US)

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 10.94 Billion
Market Forecast in 2030 (Value) USD 41.88 Billion
Growth Rate CAGR of 25.2% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Services
    • Software
  • By Type:
    • Descriptive Analytics
    • Predictive Analytics
    • Prescriptive Analytics
    • Diagnostic Analytics
  • By Application:
    • Financial Analytics
    • Clinical Analytics
    • Operational & Administrative Analytics
    • Population Health Analytics
  • By End User:
    • Payers
    • Providers
    • Pharmaceutical & Medical Supply Chain
Regions/Countries Covered China, Japan, India, Rest of Asia Pacific

WHAT IS IN IT FOR YOU: ASIA PACIFIC HEALTHCARE ANALYTICS MARKET REPORT CONTENT GUIDE

Asia Pacific Healthcare Analytics Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Large Healthcare Provider (Hospital/IDN)
  • Clinical workflow performance benchmarking
  • Cost and utilization analysis across departments
  • Patient journey mapping for chronic and acute conditions
  • Identify inefficiencies in care delivery
  • Improve operational efficiency and reduce LOS
  • Highlight opportunities for outcome improvement
Health Insurance Payer
  • Risk-adjustment and actuarial model benchmarking
  • Claims analytics and FWA (fraud-waste-abuse) mapping
  • Population health segmentation model assessment
  • Strengthen risk stratification and reimbursement accuracy
  • Reduce financial leakage
  • Improve care management and outcomes
Healthcare Analytics Platform Vendor
  • Benchmarking of analytics solutions (EHR, RWE)
  • Interoperability & HL7/FHIR capability mapping
  • AI/ML feature roadmap assessment
  • Support platform differentiation
  • Identify functional and integration gaps
  • Accelerate product adoption
Pharma & Life Sciences Company
  • RWE and outcomes analytics benchmarking
  • Market access & HEOR analytics mapping
  • Data-source capability comparison (claims, EHR, labs)
  • Improve evidence-based commercial decisions
  • Strengthen competitive positioning
  • Identify high-value patient cohorts
Healthcare Data Aggregator / Raw Data Supplier
  • Data supply-demand mapping (claims, EHR, SDOH, RPM)
  • Data quality, completeness, and granularity benchmarking
  • Mapping new partnership opportunities
  • Identify high-growth data domains
  • Improve data reliability and compliance
  • Enhance dataset breadth

RECENT DEVELOPMENTS

  • July 2025 : InterSystems and MyCLNQ Health have partnered to offer the IRIS for Health solution, which will be integrated into the white-label mobile healthcare/patient engagement apps developed by MyCLNQ. This collaboration goes a long way in enabling hospitals in several countries within the Asia Pacific region to offer analytics-enabled patient engagement applications without having to build them.
  • April 2025 : InterSystems formed a strategic partnership with an Indonesian cloud services firm, GenAl/cybersecurity services provider, and ICS Compute to accelerate the adoption of its data platform, IRIS for Health, within hospitals and clinics across Indonesia. ICS Compute will assist in data interoperability, data exchange through FHIR, analytics, and connections to Indonesia's national health data systems.
  • August 2024 : Singtel’s Digital InfraCo and the Japan-based technology firm, Hitachi, agreed with an MoU regarding the collaborative development of next-generation data centers and GPU cloud services in Japan and the APAC area. Such infrastructure development helps drive the growth of scalable AI, cloud analytics, and healthcare applications in the Asia Pacific region, serving as a backbone enabler of healthcare analytics growth.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMICS INDICATORS
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN ASIA PACIFIC HEALTHCARE IT INDUSTRY
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
5.5.1
INDICATIVE SELLING PRICE OF ASIA PACIFIC HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT (2024)
 
 
 
 
5.5.2
INDICATIVE SELLING PRICE OF ASIA PACIFIC HEALTHCARE ANALYTICS SOLUTIONS, BY COUNTRY (2024)
 
 
 
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
5.10
IMPACT OF 2025 US TARIFF – ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.10.4
IMPACT ON COUNTRIES
 
 
 
 
 
5.10.4.1
JAPAN
 
 
 
 
5.10.4.2
CHINA
 
 
 
 
5.10.4.3
INDIA
 
 
 
 
5.10.4.4
SOUTH KOREA
 
 
 
 
5.10.4.5
AUSTRALIA
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.6.2
BEST PRACTICES IN ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN THE ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
 
 
 
 
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
9
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
SERVICES
 
 
 
 
 
9.2.1
MANAGED SERVICES
 
 
 
 
 
9.2.1.1
ANALYTICAL SERVICES
 
 
 
 
9.2.1.2
CONSULTING SERVICES
 
 
 
9.2.2
PROFESSIONAL SERVICES
 
 
 
 
 
9.2.2.1
TRAINING & IMPLEMENTATION SERVICES
 
 
 
 
9.2.2.2
MAINTENANCE & SUPPORT SERVICES
 
 
9.3
SOFTWARE
 
 
 
 
 
9.3.1
ON-PREMISE SOFTWARE
 
 
 
 
9.3.2
CLOUD-BASED SOFTWARE
 
 
10
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY TYPE (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
DESCRIPTIVE ANALYTICS
 
 
 
 
10.3
PREDICTIVE ANALYTICS
 
 
 
 
10.4
PRESCRIPTIVE ANALYTICS
 
 
 
 
10.5
DIAGNOSTIC ANALYTICS
 
 
 
11
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
FINANCIAL ANALYTICS
 
 
 
 
 
11.2.1
CLAIMS PROCESSING
 
 
 
 
11.2.2
REVENUE CYCLE MANAGEMENT
 
 
 
 
11.2.3
PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
 
 
 
 
11.2.4
RISK ADJUSTMENT & ASSESSMENT
 
 
 
11.3
CLINICAL ANALYTICS
 
 
 
 
 
11.3.1
QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
 
 
 
 
11.3.2
CLINICAL DECISION SUPPORT
 
 
 
 
11.2.3
REPORTING & COMPLIANCE
 
 
 
 
11.2.4
COMPARATIVE ANALYTICS/EFFECTIVENESS
 
 
 
 
11.2.5
PRECISION HEALTH/REAL-WORLD EVIDENCE
 
 
 
 
11.2.6
MEDICAL IMAGING ANALYTICS
 
 
 
11.4
OPERATIONAL & ADMINISTRATIVE ANALYTICS
 
 
 
 
 
11.4.1
SUPPLY CHAIN ANALYTICS
 
 
 
 
11.4.2
WORKFORCE ANALYTICS
 
 
 
 
11.4.3
REPORTING & COMPLIANCE
 
 
 
11.5
POPULATION HEALTH ANALYTICS
 
 
 
12
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
PAYERS
 
 
 
 
 
12.2.1
PRIVATE INSURANCE COMPANIES
 
 
 
 
12.2.2
GOVERNMENT AGENCIES
 
 
 
12.3
PROVIDERS
 
 
 
 
 
12.3.1
HOSPITALS & CLINICS
 
 
 
 
12.3.2
POST-ACUTE CARE ORGANIZATIONS
 
 
 
 
12.3.3
AMBULATORY SURGERY CENTERS
 
 
 
 
12.3.4
OTHER PROVIDERS
 
 
 
12.4
PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
 
 
 
 
 
12.4.1
MANUFACTURERS
 
 
 
 
12.4.2
DISTRIBUTORS & WHOLESALERS
 
 
 
 
12.4.3
RETAILERS
 
 
13
ASIA PACIFIC TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.3.1
CHINA
 
 
 
 
13.3.2
JAPAN
 
 
 
 
13.3.3
INDIA
 
 
 
 
13.3.4
AUSTRALIA
 
 
 
 
13.3.5
SOUTH KOREA
 
 
 
 
13.4.6
REST OF ASIA PACIFIC
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
14.1
OVERVIEW
 
 
 
 
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
 
 
 
 
14.3
REVENUE ANALYSIS (2020–2024)
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS (2024)
 
 
 
 
 
14.5
BRAND COMPARISON
 
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
14.6.1
STARS
 
 
 
 
14.6.2
EMERGING LEADERS
 
 
 
 
14.6.3
PERVASIVE PLAYERS
 
 
 
 
14.6.4
PARTICIPANTS
 
 
 
 
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
14.6.5.1
COMPANY FOOTPRINT
 
 
 
 
14.6.5.2
COUNTRY FOOTPRINT
 
 
 
 
14.6.5.3
COMPONENT FOOTPRINT
 
 
 
 
14.6.5.4
APPLICATION FOOTPRINT
 
 
 
 
14.6.5.5
END-USER FOOTPRINT
 
 
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
14.7.1
PROGRESSIVE COMPANIES
 
 
 
 
14.7.2
RESPONSIVE COMPANIES
 
 
 
 
14.7.3
DYNAMIC COMPANIES
 
 
 
 
14.7.4
STARTING BLOCKS
 
 
 
 
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
14.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES
 
 
 
 
14.9.2
DEALS
 
 
 
 
14.9.3
EXPANSIONS
 
 
 
 
14.9.4
OTHER DEVELOPMENTS
 
 
15
COMPANY PROFILES
 
 
 
 
 
15.1
KEY PLAYERS
 
 
 
 
 
15.1.1
MERATIVE
 
 
 
 
15.1.2
SAS INSTITUTE INC.
 
 
 
 
15.1.3
OPTUM, INC.
 
 
 
 
15.1.4
ORACLE
 
 
 
 
15.1.5
VERADIGM LLC
 
 
 
 
15.1.6
EXLSERVICE HOLDINGS, INC.
 
 
 
 
15.1.7
CITIUSTECH INC.
 
 
 
 
15.1.8
HEALTH CATALYST
 
 
 
 
15.1.9
CVS HEALTH
 
 
 
 
15.1.10
INOVALON
 
 
 
 
15.1.11
MCKESSON CORPORATION
 
 
 
 
15.1.12
COTIVITI, INC.
 
 
 
 
15.1.15
ENLITIC
 
 
 
 
15.1.15
KOMODO HEALTH, INC.
 
 
 
 
15.1.15
HEALTHEC, LLC
 
 
 
 
15.1.16
IQVIA
 
 
 
 
15.1.15
WIPRO
 
 
 
 
15.1.18
INTERSYSTEMS CORPORATION
 
 
 
 
15.1.19
KONINKLIJKE PHILIPS N.V.
 
 
 
 
15.1.20
INFOR
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
15.2.1
TREDENCE.INC.
 
 
 
 
15.2.2
HEAPS HEALTH SOLUTIONS INDIA PRIVATE LIMITED
 
 
 
 
15.2.3
MYHEALTHCARE TECHNOLOGIES PRIVATE LIMITED
 
 
 
 
15.2.4
HOLMUSK
 
 
 
 
15.2.5
ATHENAHEALTH INC.
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
16.2.3
BASE NUMBER CALCULATION
 
 
 
16.3
MARKET FORECAST APPROACH
 
 
 
 
 
16.3.1
SUPPLY SIDE
 
 
 
 
16.3.2
DEMAND SIDE
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
16.5
FACTOR ANALYSIS
 
 
 
 
16.6
RESEARCH ASSUMPTIONS
 
 
 
 
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
17
APPENDIX
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 

Methodology

The study involved five major activities to estimate the current size of theAsia Pacific Healthcare Analytics Market . Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study ofAsia Pacific Healthcare Analytics Market . It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the globalAsia Pacific Healthcare Analytics Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of theAsia Pacific Healthcare Analytics Market . These methods were also used extensively to estimate the size of various subsegments in the market.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in theAsia Pacific Healthcare Analytics Market .

Market Definition

Healthcare analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, diagnostics, and other emerging applied analytical models. These tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for the improved clinical, financial, and operational performance of healthcare organizations.

Stakeholders

  • Stakeholders
  • Healthcare IT firms
  • Healthcare Analytics Vendors
  • Health Insurance Exchanges
  • Healthcare Payers
  • Healthcare Providers
  • Venture Capitalists
  • Research and Consulting Firms
  • Accountable Care Organizations (ACOs)

Report Objectives

  • To define, describe, and forecast the globalAsia Pacific Healthcare Analytics Market based on component, type, application, end-user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overallAsia Pacific Healthcare Analytics Market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile the key players of theAsia Pacific Healthcare Analytics Market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in theAsia Pacific Healthcare Analytics Market during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Asia Pacific Healthcare Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Asia Pacific Healthcare Analytics Market

DMCA.com Protection Status